9R8S
A viral SAVED protein with ring nuclease activity subverts type III CRISPR defence
Summary for 9R8S
| Entry DOI | 10.2210/pdb9r8s/pdb |
| Descriptor | SMODS-associated and fused to various effectors domain-containing protein, PHOSPHATE ION (3 entities in total) |
| Functional Keywords | saved anti-crispr defense, viral protein |
| Biological source | Thermocrinis Great Boiling Spring virus |
| Total number of polymer chains | 2 |
| Total formula weight | 55451.65 |
| Authors | McMahon, S.A.,White, M.F.,Orzechowski, M.,Hoikkala, V.,Chi, H.,Gloster, T.M. (deposition date: 2025-05-16, release date: 2025-07-02, Last modification date: 2025-11-26) |
| Primary citation | Orzechowski, M.,Hoikkala, V.,Chi, H.,McMahon, S.,Gloster, T.,White, M.F. A viral SAVED protein with ring nuclease activity degrades the CRISPR second messenger cA4. Biochem.J., 482:-, 2025 Cited by PubMed Abstract: Type III CRISPR systems typically generate cyclic oligoadenylate second messengers such as cyclic tetra-adenylate (cA4) on detection of foreign RNA. These activate ancillary effector proteins which elicit a diverse range of immune responses. The Calp (CRISPR associated Lon protease) system elicits a transcriptional response to infection when CalpL (Calp Lon protease) binds cA4 in its SAVED (SMODS associated and fused to various effectors domain) sensor domain, resulting in filament formation and activation of the Lon protease domain, which cleaves the anti-Sigma factor CalpT, releasing the CalpS (Calp Sigma factor) for transcriptional remodelling. Here, we show that thermophilic viruses have appropriated the SAVED domain of CalpL as an anti-CRISPR, AcrIII-2 (second anti-CRISPR of type III systems), which they use to degrade cA4. AcrIII-2 dimers sandwich cA4, degrading it in a shared active site to short linear products, using a mechanism highly reminiscent of CalpL. This results in inhibition of a range of cA4 activated effectors in vitro. This is the first example of a virally encoded SAVED domain with ring nuclease activity, highlighting the complex interplay between viruses and cellular defences. PubMed: 41190788DOI: 10.1042/BCJ20253271 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (1.79 Å) |
Structure validation
Download full validation report






